e-Drug3D

106

DIPHEMANIL

DISCONTINUED

INN
DIPHEMANIL

cas 15394-62-4

CLASS

METABOLISM
TREATMENT OF DERMATOSES
ANTICHOLINERGIC
ANTIMUSCARINIC

ROUTE (list)

ORAL

PK parameters

Tmax 3 HOUR
t1/2 8.35 HOUR

Target

TARGET MUSCARINIC ACETYLCHOLINE RECEPTOR

Muscarinic acetylcholine receptor M1 UNIPROT P11229 CHRM1

Muscarinic acetylcholine receptor M3 UNIPROT P20309 CHRM3

Download SDF file

4-benzhydrylidene-1,1-dimethylpiperidin-1-ium

Formula:
C20H24N

Calculated chemical properties:

MW 278.40
NB_atoms 21
XLogP 4.36
PSA 0.167
NB_HD 0
NB_HA 0
fsp3 0.30
Lipinski(0=no;1=yes) 1

FDA
NDA 008114 (pdf not found) INN (DIPHEMANIL METHYLSULFATE) PRANTAL (SCHERING) APPROVAL= AP YEAR= 1976 DISCONTINUED